4.4 Review

Is the shape of the decline in risk following quitting smoking similar for squamous cell carcinoma and adenocarcinoma of the lung? A quantitative review using the negative exponential model

期刊

REGULATORY TOXICOLOGY AND PHARMACOLOGY
卷 72, 期 1, 页码 49-57

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yrtph.2015.02.010

关键词

Smoking; Lung cancer; Histological type; Cessation of smoking; Statistical models; Negative exponential model; Meta-analysis; Review

资金

  1. Altria Client Services Inc.

向作者/读者索取更多资源

One possible contributor to the reported rise in the ratio of adenocarcinoma to squamous cell carcinoma of the lung may be differences in the pattern of decline in risk following quitting for the two lung cancer types. Earlier, using data from 85 studies comparing overall lung cancer risks in current smokers, quitters (by time quit) and never smokers, we fitted the negative exponential model, deriving an estimate of 9.93 years for the half-life - the time when the excess risk for quitters compared to never smokers becomes half that for continuing smokers. Here we applied the same techniques to data from 16 studies providing RRs specific for lung cancer type. From the 13 studies where the half-life was estimable for each type, we derived estimates of 11.68 (95% CI 10.22-13.34) for squamous cell carcinoma and 14.45 (11.92-17.52) for adenocarcinoma. The ratio of the half-lives was estimated as 1.32 (95% CI 1.20-1.46, p < 0.001). The slower decline in quitters for adenocarcinoma, evident in subgroups by sex, age and other factors, may be one of the factors contributing to the reported rise in the ratio of adenocarcinoma to squamous cell carcinoma. Others include changes in the diagnosis and classification of lung cancer. (C) 2015 The Authors. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Toxicology

A systematic review of possible serious adverse health effects of nicotine replacement therapy

Peter N. Lee, Marc W. Fariss

ARCHIVES OF TOXICOLOGY (2017)

Article Medicine, Legal

Time trends in never smokers in the relative frequency of the different histological types of lung cancer, in particular adenocarcinoma

Peter N. Lee, Barbara A. Forey, Katharine J. Coombs, Peter J. Lipowicz, Scott Appleton

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)

Article Medicine, Legal

Epidemiological evidence on environmental tobacco smoke and cancers other than lung or breast

Peter N. Lee, Alison J. Thornton, Janette S. Hamling

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)

Article Neurosciences

Environmental Tobacco Smoke Exposure and Risk of Stroke in Never Smokers: An Updated Review with Meta-Analysis

Peter N. Lee, Alison J. Thornton, Barbara A. Forey, Jan S. Hamling

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)

Article Medicine, Legal

Investigation into the risk of ultra-low tar cigarettes and lung cancer

Peter N. Lee, John S. Fry, Janette S. Hamling

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)

Article Medicine, Legal

The relationship of snus use to diabetes and allied conditions

Peter N. Lee, Alison J. Thornton

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)

Article Medicine, Legal

Estimating the effect of differing assumptions on the population health impact of introducing a Reduced Risk Tobacco Product in the USA

Peter N. Lee, John S. Fry, John F. Hamling, Zheng Sponsiello-Wang, Gizelle Baker, Rolf Weitkunat

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)

Article Neurosciences

Environmental Tobacco Smoke Exposure and Risk of Stroke in Never Smokers: An Updated Review with Meta-Analysis

Peter N. Lee, Alison J. Thornton, Barbara A. Forey, Jan S. Hamling

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2017)

Review Toxicology

Tar level of cigarettes smoked and risk of smoking-related diseases

Peter N. Lee

INHALATION TOXICOLOGY (2018)

Letter Oncology

Cigarette Filter Ventilation and Biomarkers

Peter Lee, John Fry

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Toxicology

Estimating the reduction in US mortality if cigarettes were largely replaced by e-cigarettes

Peter N. Lee, John S. Fry, Stanley Gilliland, Preston Campbell, Andrew R. Joyce

Summary: Recent estimates suggest that substantial reductions in deaths and life-years lost can be achieved through replacing cigarettes with e-cigarettes, even under pessimistic assumptions. Results varied most for X and F among the parameters considered, indicating the importance of these factors in impacting outcomes.

ARCHIVES OF TOXICOLOGY (2022)

Article Health Care Sciences & Services

Modeling the Population Health Impact of Introducing a Modified Risk Tobacco Product into the U.S. Market

Smilja Djurdjevic, Peter N. Lee, Rolf Weitkunat, Zheng Sponsiello-Wang, Frank Ludicke, Gizelle Baker

HEALTHCARE (2018)

Article Medicine, Legal

New supporting data to guide the use of evident toxicity in acute oral toxicity studies (OECD TG 420)

Fiona Sewell, Ian Ragan, Graham Horgan, David Andrew, Thomas Holmes, Irene Manou, Boris P. Mueller, Tim Rowan, Barbara G. Schmitt, Marco Corvaro

Summary: There are currently three test guidelines for acute oral toxicity studies, but the subjectivity of one guideline may be hindering its wider use. In order to address this, the NC3Rs and EPAA collaborated to analyze historical data and provide recommendations on the recognition of 'evident toxicity'.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)

Article Medicine, Legal

The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls

Michael DeVito, Bas Bokkers, Majorie B. M. van Duursen, Karin van Ede, Mark Feeley, Elsa Antunes Fernandes Gaspar, Laurie Haws, Sean Kennedy, Richard E. Peterson, Ron Hoogenboom, Keiko Nohara, Kim Petersen, Cynthia Rider, Martin Rose, Stephen Safe, Dieter Schrenk, Matthew W. Wheeler, Daniele S. Wikoff, Bin Zhao, Martin van den Berg

Summary: In October 2022, the World Health Organization reevaluated the toxic equivalency factors (TEFs) for chlorinated dioxin-like compounds in a panel convened in Lisbon. This effort utilized an updated database, Bayesian dose response modeling, and meta-analysis to derive Best-Estimate TEFs. Applying these new TEFs may result in lower total toxic equivalents for dioxin-like chemicals.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)